The investigators reported that oral AOD-9604 administration in rodent models produced measurable increases in fat oxidation and reductions in body fat, and that direct application of the compound to ex vivo human adipose tissue produced concentration-dependent increases in lipolysis [2]
Gastrointestinal Cytoprotection Research The earliest and most extensively characterized research application of BPC-157 involves cytoprotection-associated endpoints in gastrointestinal mucosa models
Used as part of bulk compound ingredients, it is listed by the FDA as a Category 2 ingredient and that compounding them will present numerous safety challenges
These side effects are typically minor and short-lived
It is not intended for human consumption, medical use, therapeutic use, or veterinary use
But if the inflammation is being fueled by diet (processed seed oils, excess sugar, food sensitivities, alcohol), the peptides are constantly fighting upstream